Photographic negative shadow of pulmonary oedema

Abstract

Roche European American Cataract Trial (REACT): a randomized clinical trial to investigate the efficacy of an oral antioxidant micronutrient mixture to slow progression of age-related cataract. Ophthalmic Epidemiol 2002; 9: 49–80. 53 Robman LD, McCarty CA, Tikellis G, et al. VECAT study: the effect of vitamin E on the progression of lens opacities (preliminary results). IOVS 2001; 42: S508 (abstr). 54 Christen WG. Beta-carotene and age-related cataract in a randomized trial of US physicians. IOVS 2001; 42: S518 (abstr). 55 Steinberg D, Witztum JL. Is the oxidative modification hypothesis relevant to human atherosclerosis? Do the antioxidant trials conducted to date refute the hypothesis? Circulation 2002; 105: 2107–11. 56 Willett WC, Stampfer MJ. What vitamins should I be taking, doctor? N Engl J Med 2001; 345: 1819–24. 57 Sundaram RK, Bhaskar A, Vijayalingam S, Viswanathan M, Mohan R, Shanmugasundaram KR. Antioxidant status and lipid peroxidation in type II diabetes mellitus with and without complications. Clin Sci 1996; 90: 255–60. 58 Chen J, Campbell TC, Li J, Peto R. Diet, life-style and mortality in China. Oxford: Oxford University Press, 1990 (updated on www.ctsu.ox.ac.uk). 59 Brigelius-Flohe, Traber MG. Vitamin E: function and metabolism. FASEB J 1999; 13: 1145–55. 60 Hoppe PP, Krennrich G. Bioavailability and potency of natural-source and all-racemic -tocopherol in the human: a dispute. Eur J Nutr 2000; 39: 183–93. 61 Keech A, Collins R, Peto R, et al. Vitamin E supplementation inhibits LDL oxidation in patients at risk of coronary disease taking simvastatin or placebo. XI Int Symp Drugs Lip Met 1992; 59 (abstr). 62 Levine M, Wang Y, Padayatty SJ, Morrow J. A new recommended dietary allowance of vitamin C for healthy young women. Proc Natl Acad Sci 2001; 98: 9842–46. 63 Scandinavian Simvastatin Survival Study Group. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian simvastatin survival study (4S). Lancet 1994; 344: 1383–89. 64 Sacks FM, Tonkin AM, Shepherd J, et al, for the Prospective Pravastatin Pooling Project Investigators Group. Effect of pravastatin on coronary disease events in subgroups defined by coronary risk factors: the Prospective Pravastatin Pooling Project. Circulation 2000; 102: 1893–900. 65 Benzie IFF, Strain JJ. The effect of ascorbic acid on the measurement of total cholesterol and triglycerides: possible artefactual lowering in individuals with high plasma concentration of ascorbic acid. Clinica Chimica Acta 1995; 239: 185–90. 66 Omenn GS, Goodman GE, Thornquist M, Brunzell JD. Long-term vitamin A does not produce clinically significant hypertriglyceridemia: results from CARET, the -carotene and retinol efficacy trial. Cancer Epidemiol Biomarkers Prev 1994; 3: 711–13. ARTICLES